Literature DB >> 22281427

Alternative activation in systemic juvenile idiopathic arthritis monocytes.

Claudia Macaubas1, Khoa D Nguyen, Ariana Peck, Julia Buckingham, Chetan Deshpande, Elizabeth Wong, Heather C Alexander, Sheng-Yung Chang, Ann Begovich, Yue Sun, Jane L Park, Kuang-Hung Pan, Richard Lin, Chih-Jian Lih, Erin M Augustine, Carolyn Phillips, Andreas V Hadjinicolaou, Tzielan Lee, Elizabeth D Mellins.   

Abstract

Systemic juvenile idiopathic arthritis (SJIA) is a chronic autoinflammatory condition. The association with macrophage activation syndrome, and the therapeutic efficacy of inhibiting monocyte-derived cytokines, has implicated these cells in SJIA pathogenesis. To characterize the activation state (classical/M1 vs. alternative/M2) of SJIA monocytes, we immunophenotyped monocytes using several approaches. Monocyte transcripts were analyzed by microarray and quantitative PCR. Surface proteins were measured at the single cell level using flow cytometry. Cytokine production was evaluated by intracellular staining and ELISA. CD14(++)CD16(-) and CD14(+)CD16(+) monocyte subsets are activated in SJIA. A mixed M1/M2 activation phenotype is apparent at the single cell level, especially during flare. Consistent with an M2 phenotype, SJIA monocytes produce IL-1β after LPS exposure, but do not secrete it. Despite the inflammatory nature of active SJIA, circulating monocytes demonstrate significant anti-inflammatory features. The persistence of some of these phenotypes during clinically inactive disease argues that this state reflects compensated inflammation. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22281427      PMCID: PMC3288602          DOI: 10.1016/j.clim.2011.12.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  70 in total

1.  International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

Authors:  Ross E Petty; Taunton R Southwood; Prudence Manners; John Baum; David N Glass; Jose Goldenberg; Xiaohu He; Jose Maldonado-Cocco; Javier Orozco-Alcala; Anne-Marie Prieur; Maria E Suarez-Almazor; Patricia Woo
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

2.  Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation.

Authors:  E C Baechler; F M Batliwalla; G Karypis; P M Gaffney; K Moser; W A Ortmann; K J Espe; S Balasubramanian; K M Hughes; J P Chan; A Begovich; S-Y P Chang; P K Gregersen; T W Behrens
Journal:  Genes Immun       Date:  2004-08       Impact factor: 2.676

3.  Identification of novel functional differences in monocyte subsets using proteomic and transcriptomic methods.

Authors:  Changqing Zhao; Huoming Zhang; Wing-Cheong Wong; Xiaohui Sem; Hao Han; Siew-Min Ong; Yann-Chong Tan; Wei-Hseun Yeap; Chee-Sian Gan; Kok-Quan Ng; Mickey Boon-Chai Koh; Philippe Kourilsky; Siu-Kwan Sze; Siew-Cheng Wong
Journal:  J Proteome Res       Date:  2009-08       Impact factor: 4.466

4.  CD14(dim)/CD16(bright) monocytes in hemophagocytic lymphohistiocytosis.

Authors:  W Emminger; G J Zlabinger; G Fritsch; R Urbanek
Journal:  Eur J Immunol       Date:  2001-06       Impact factor: 5.532

5.  Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation.

Authors:  Monica Guma; Lisa Ronacher; Ru Liu-Bryan; Shinji Takai; Michael Karin; Maripat Corr
Journal:  Arthritis Rheum       Date:  2009-12

6.  Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss.

Authors:  Judith Aron-Wisnewsky; Joan Tordjman; Christine Poitou; Froogh Darakhshan; Danielle Hugol; Arnaud Basdevant; Abdelhalim Aissat; Michèle Guerre-Millo; Karine Clément
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

7.  Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB.

Authors:  Chiara Porta; Monica Rimoldi; Geert Raes; Lea Brys; Pietro Ghezzi; Diana Di Liberto; Francesco Dieli; Serena Ghisletti; Gioacchino Natoli; Patrick De Baetselier; Alberto Mantovani; Antonio Sica
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

8.  Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation.

Authors:  Anja B Geldhof; Jo A Van Ginderachter; YuanQing Liu; Wim Noël; Geert Raes; Patrick De Baetselier
Journal:  Blood       Date:  2002-07-25       Impact factor: 22.113

Review 9.  Oligoarticular and polyarticular JIA: epidemiology and pathogenesis.

Authors:  Claudia Macaubas; Khoa Nguyen; Diana Milojevic; Jane L Park; Elizabeth D Mellins
Journal:  Nat Rev Rheumatol       Date:  2009-10-06       Impact factor: 20.543

10.  Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets.

Authors:  Petronela Ancuta; Kuang-Yu Liu; Vikas Misra; Vanessa Sue Wacleche; Annie Gosselin; Xiaobo Zhou; Dana Gabuzda
Journal:  BMC Genomics       Date:  2009-08-27       Impact factor: 3.969

View more
  20 in total

1.  Interleukin-1 in monocyte activation phenotypes in systemic juvenile idiopathic arthritis: Observations from a clinical trial of rilonacept, an interleukin-1 inhibitor.

Authors:  Yujuan Zhang; Saloni Gupta; Alexandra Ilstad-Minnihan; Sashi Ayyangar; Arielle D Hay; Virginia Pascual; Norman T Ilowite; Claudia Macaubas; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2018-06-19       Impact factor: 3.969

2.  Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes.

Authors:  Grant S Schulert; Ndate Fall; John B Harley; Nan Shen; Daniel J Lovell; Sherry Thornton; Alexei A Grom
Journal:  Arthritis Rheumatol       Date:  2016-09       Impact factor: 10.995

Review 3.  Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.

Authors:  Yvan Jamilloux; Mathieu Gerfaud-Valentin; Fabio Martinon; Alexandre Belot; Thomas Henry; Pascal Sève
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

4.  Diacylglycerol Kinase ζ Regulates Macrophage Responses in Juvenile Arthritis and Cytokine Storm Syndrome Mouse Models.

Authors:  Sahil Mahajan; Elizabeth D Mellins; Roberta Faccio
Journal:  J Immunol       Date:  2019-12-04       Impact factor: 5.422

5.  Plcγ2/Tmem178 dependent pathway in myeloid cells modulates the pathogenesis of cytokine storm syndrome.

Authors:  Sahil Mahajan; Corinne E Decker; Zhengfeng Yang; Deborah Veis; Elizabeth D Mellins; Roberta Faccio
Journal:  J Autoimmun       Date:  2019-03-15       Impact factor: 7.094

6.  Altered signaling in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Elizabeth Wong; Yujuan Zhang; Khoa D Nguyen; Justin Lee; Diana Milojevic; Susan Shenoi; Anne M Stevens; Norman Ilowite; Vivian Saper; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2015-12-31       Impact factor: 3.969

Review 7.  Biomarkers in systemic juvenile idiopathic arthritis: a comparison with biomarkers in cryopyrin-associated periodic syndromes.

Authors:  Nanguneri Nirmala; Alexei Grom; Hermann Gram
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

8.  A Multiparameter Flow Cytometry Analysis Panel to Assess CD163 mRNA and Protein in Monocyte and Macrophage Populations in Hyperinflammatory Diseases.

Authors:  Sherry Thornton; Rachel Tan; Alyssa Sproles; Thuy Do; Jonathan Schick; Alexei A Grom; Monica DeLay; Grant S Schulert
Journal:  J Immunol       Date:  2019-01-25       Impact factor: 5.422

9.  Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis.

Authors:  Lauren A Henderson; Kacie J Hoyt; Pui Y Lee; Deepak A Rao; A Helena Jonsson; Jennifer P Nguyen; Kayleigh Rutherford; Amélie M Julé; Louis-Marie Charbonnier; Siobhan Case; Margaret H Chang; Ezra M Cohen; Fatma Dedeoglu; Robert C Fuhlbrigge; Olha Halyabar; Melissa M Hazen; Erin Janssen; Susan Kim; Jeffrey Lo; Mindy S Lo; Esra Meidan; Mary Beth F Son; Robert P Sundel; Matthew L Stoll; Chad Nusbaum; James A Lederer; Talal A Chatila; Peter A Nigrovic
Journal:  JCI Insight       Date:  2020-03-26

10.  Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis.

Authors:  Norman T Ilowite; Kristi Prather; Yuliya Lokhnygina; Laura E Schanberg; Melissa Elder; Diana Milojevic; James W Verbsky; Steven J Spalding; Yukiko Kimura; Lisa F Imundo; Marilynn G Punaro; David D Sherry; Stacey E Tarvin; Lawrence S Zemel; James D Birmingham; Beth S Gottlieb; Michael L Miller; Kathleen O'Neil; Natasha M Ruth; Carol A Wallace; Nora G Singer; Christy I Sandborg
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.